B. Nagy

Role of Glucagon-Like Peptide -1 Receptor in Pulmonary Circulation

N. Chandran, B. Nagy, E. Kathrin, W. Klepetko +2 more

TP85. TP085 A HARD DAY?S NIGHT - NOVEL MOLECULAR MECHANISMS AND TREATMENT OPTIONS IN PAH AND BEYOND: FROM PULMONARY VASCULATURE TO RV0 citations Open access

Semantic Scholar

B. Nagy

Most-cited papers

A randomized clinical trial of manual therapy for cervico-brachial pain syndrome -- a pilot study.

TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications

Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension

Importance of kynurenine in pulmonary hypertension.

Disconnect between Fibrotic Response and Right Ventricular Dysfunction.

Right ventricular fibrosis and dysfunction: Actual concepts and common misconceptions.

Pressure Overload Creates Right Ventricular Diastolic Dysfunction in a Mouse Model: Assessment by Echocardiography.

Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension

Machine Learning Analysis of the Bleomycin Mouse Model Reveals the Compartmental and Temporal Inflammatory Pulmonary Fingerprint

Nano- and Micropatterned Polycaprolactone Cellulose Composite Surfaces with Tunable Protein Adsorption, Fibrin Clot Formation, and Endothelial Cellular Response

Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox

Endothelial Dysfunction Following Enhanced TMEM16A Activity in Human Pulmonary Arteries

Lack of ABCG2 Leads to Biventricular Dysfunction and Remodeling in Response to Hypoxia

Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension

Adventitial fibroblasts direct smooth muscle cell-state transition in pulmonary vascular disease

Antithrombogenic polysaccharide coatings to improve hemocompatibility, protein-repellence, and endothelial cell response

IDO‐1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension

Machine learning analysis of the bleomycin-mouse model reveals spatial 1 and temporal pulmonary inflammatory fingerprint

TMEM16A Potentiation: Possible Drawbacks

Lipidomics for diagnosis and prognosis of pulmonary hypertension

RGS5 Determines Neutrophil Migration in the Acute Inflammatory Phase of Bleomycin-Induced Lung Injury

No indication of insulin resistance in idiopathic pulmonary arterial hypertension with preserved physical activity

Late Breaking Abstract - Metabolic phenotype determines outcome of pulmonary arterial hypertension

Synergistic Effects of Nintedanib and Sildenafil on the Pulmonary Vasculature

An intrinsic tryptophan metabolite acts as pulmonary vasodilator in pulmonary hypertension

Impact of GLP1R and its agonists in pulmonary circulation

Modelling of the Inflammatory Cell Kinetics Underlying Bleomycin-Induced Lung Fibrosis Reveals Chronic Persistent Inflammation

THU0340 IMPACT OF LANIFIBRANOR, A PAN-PPAR AGONIST, ON THE PULMONARY VASCULAR TONE

The role of ABCG2 transporter in Pulmonary Hypertension (PH)

Abstract 17865: Right Ventricular Diastolic Dysfunction in ABCG2 knockout mice under Hypoxia

Loss of ABCG2 leads to right ventricular diastolic dysfunction in pulmonary hypertension

Randomised placebo controlled trial for cervicobrachial pain syndrome using manual therapy

Role of Glucagon-Like Peptide -1 Receptor in Pulmonary Circulation